253 related articles for article (PubMed ID: 27647784)
1. Pulmonary artery pressure-guided heart failure management: US cost-effectiveness analyses using the results of the CHAMPION clinical trial.
Martinson M; Bharmi R; Dalal N; Abraham WT; Adamson PB
Eur J Heart Fail; 2017 May; 19(5):652-660. PubMed ID: 27647784
[TBL] [Abstract][Full Text] [Related]
2. The cost-effectiveness of real-time pulmonary artery pressure monitoring in heart failure patients: a European perspective.
Cowie MR; Simon M; Klein L; Thokala P
Eur J Heart Fail; 2017 May; 19(5):661-669. PubMed ID: 28176424
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of remote haemodynamic monitoring by an implantable pulmonary artery pressure monitoring sensor (CardioMEMS-HF system) in chronic heart failure in the Netherlands.
Mokri H; Clephas PRD; de Boer RA; van Baal P; Brugts JJ; Rutten-van Mölken MPMH
Eur J Heart Fail; 2024 May; 26(5):1189-1198. PubMed ID: 38560762
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness of Implantable Pulmonary Artery Pressure Monitoring in Chronic Heart Failure.
Sandhu AT; Goldhaber-Fiebert JD; Owens DK; Turakhia MP; Kaiser DW; Heidenreich PA
JACC Heart Fail; 2016 May; 4(5):368-75. PubMed ID: 26874380
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Remote Cardiac Monitoring With the CardioMEMS Heart Failure System.
Schmier JK; Ong KL; Fonarow GC
Clin Cardiol; 2017 Jul; 40(7):430-436. PubMed ID: 28272808
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort - The WHICH? study (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care).
Maru S; Byrnes J; Carrington MJ; Chan YK; Thompson DR; Stewart S; Scuffham PA;
Int J Cardiol; 2015 Dec; 201():368-75. PubMed ID: 26310979
[TBL] [Abstract][Full Text] [Related]
7. Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management.
Bhatt AS; Vaduganathan M; Claggett BL; Fonarow GC; Packer M; Pfeffer MA; Shah SJ; Shen X; Cristino J; McMurray JJV; Solomon SD; Gaziano TA
JAMA Cardiol; 2023 Nov; 8(11):1041-1048. PubMed ID: 37755814
[TBL] [Abstract][Full Text] [Related]
8. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.
Pufulete M; Maishman R; Dabner L; Mohiuddin S; Hollingworth W; Rogers CA; Higgins J; Dayer M; Macleod J; Purdy S; McDonagh T; Nightingale A; Williams R; Reeves BC
Health Technol Assess; 2017 Aug; 21(40):1-150. PubMed ID: 28774374
[TBL] [Abstract][Full Text] [Related]
10. Safety and feasibility of pulmonary artery pressure-guided heart failure therapy: rationale and design of the prospective CardioMEMS Monitoring Study for Heart Failure (MEMS-HF).
Angermann CE; Assmus B; Anker SD; Brachmann J; Ertl G; Köhler F; Rosenkranz S; Tschöpe C; Adamson PB; Böhm M
Clin Res Cardiol; 2018 Nov; 107(11):991-1002. PubMed ID: 29777373
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of supervised exercise therapy in heart failure patients.
Kühr EM; Ribeiro RA; Rohde LE; Polanczyk CA
Value Health; 2011; 14(5 Suppl 1):S100-7. PubMed ID: 21839879
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a Heart Failure Telemonitoring Program Through a Microsimulation Model: Cost-Utility Analysis.
Boodoo C; Zhang Q; Ross HJ; Alba AC; Laporte A; Seto E
J Med Internet Res; 2020 Oct; 22(10):e18917. PubMed ID: 33021485
[TBL] [Abstract][Full Text] [Related]
13. The cost effectiveness of REACH-HF and home-based cardiac rehabilitation compared with the usual medical care for heart failure with reduced ejection fraction: A decision model-based analysis.
Taylor RS; Sadler S; Dalal HM; Warren FC; Jolly K; Davis RC; Doherty P; Miles J; Greaves C; Wingham J; Hillsdon M; Abraham C; Frost J; Singh S; Hayward C; Eyre V; Paul K; Lang CC; Smith K
Eur J Prev Cardiol; 2019 Aug; 26(12):1252-1261. PubMed ID: 30884975
[TBL] [Abstract][Full Text] [Related]
14. Economic Outcomes of Rehabilitation Therapy in Older Patients With Acute Heart Failure in the REHAB-HF Trial: A Secondary Analysis of a Randomized Clinical Trial.
Chew DS; Li Y; Zeitouni M; Whellan DJ; Kitzman D; Mentz RJ; Duncan P; Pastva AM; Reeves GR; Nelson MB; Chen H; Reed SD
JAMA Cardiol; 2022 Feb; 7(2):140-148. PubMed ID: 34817542
[TBL] [Abstract][Full Text] [Related]
15. Real-time pulmonary artery pressure monitoring in heart failure patients: an updated cost-effectiveness analysis.
Cowie MR; Thokala P; Ihara Z; Adamson PB; Angermann C
ESC Heart Fail; 2023 Oct; 10(5):3046-3054. PubMed ID: 37591524
[TBL] [Abstract][Full Text] [Related]
16. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.
Colquitt JL; Mendes D; Clegg AJ; Harris P; Cooper K; Picot J; Bryant J
Health Technol Assess; 2014 Aug; 18(56):1-560. PubMed ID: 25169727
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure).
Sanders-van Wijk S; van Asselt AD; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Vuillomenet A; Peter M; Pfisterer ME; Brunner-La Rocca HP;
JACC Heart Fail; 2013 Feb; 1(1):64-71. PubMed ID: 24621800
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of sacubitril/valsartan versus enalapril in patients with heart failure and reduced ejection fraction.
Liang L; Bin-Chia Wu D; Aziz MIA; Wong R; Sim D; Leong KTG; Wei YQ; Tan D; Ng K
J Med Econ; 2018 Feb; 21(2):174-181. PubMed ID: 28959905
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction.
Gaziano TA; Fonarow GC; Claggett B; Chan WW; Deschaseaux-Voinet C; Turner SJ; Rouleau JL; Zile MR; McMurray JJ; Solomon SD
JAMA Cardiol; 2016 Sep; 1(6):666-72. PubMed ID: 27438344
[TBL] [Abstract][Full Text] [Related]
20. Long-term cost-effectiveness analysis of nebivolol compared with standard care in elderly patients with heart failure: an individual patient-based simulation model.
Yao G; Freemantle N; Flather M; Tharmanathan P; Coats A; Poole-Wilson PA;
Pharmacoeconomics; 2008; 26(10):879-89. PubMed ID: 18793034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
